HomeStrategyA $435 Million Bet on ‘Reversing Aging’ Strategy A $435 Million Bet on ‘Reversing Aging’ Strategy June 7, 2026 0 254 FacebookXPinterestWhatsApp Biotech startup NewLimit secures a major funding round after claiming a ‘breakthrough discovery’ of a prototype medicine that rewinds cellular aging in the liver. FacebookXPinterestWhatsApp Cody Previous articleDell sharpens data protection strategy as AI reshapes cyber resilienceNext articleLayoffs don’t have to feel inhumane RELATED ARTICLES Strategy Harvard Business School’s Howard Stevenson Defined Entrepreneurship in 10 Brilliant Words. His Work Changed My Life Strategy You Don’t Need a Big Company’s Budget to Borrow Its Best Systems. Here’s How. Strategy Details about ‘Cornell 7’ rape lawsuit have been exposed by social media, but some worry they’re being throttled Strategy ‘Zombie BBLs’: Fat from dead bodies is being used in butt filler—and Dakota Johnson just made the cosmetic surgery trend go viral Must Read Harvard Business School’s Howard Stevenson Defined Entrepreneurship in 10 Brilliant Words. His Work Changed My Life Strategy AI agent identity security demands layered defenses, Omdia says Tech Okta builds shared architecture for agent runtime security Tech Former Miami Dolphins star Tyreek Hill lists Southwest Ranches estate Real Estate Florida AG asks court to prevent OpenAI from advancing its frontier models, as company scraps new one Tech